Medical Care
Global Gene Delivery System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 09, 25
- ID: 427832
- Pages: 105
- Figures: 101
- Views: 3
The global Gene Delivery System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Adaptimmune
Krystal Biotech
Vertex Pharmaceuticals
CSL Behring
By Type: (Dominant Segment vs High-Margin Innovation)
Viral Gene Delivery System
Non-viral Gene Delivery System
By Application: (Core Demand Driver vs Emerging Opportunity)
Neurological Diseases
Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Biogen in Europe)
- Emerging Product Trends: Viral Gene Delivery System adoption vs. Non-viral Gene Delivery System premiumization
- Demand-Side Dynamics: Neurological Diseases growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Gene Delivery System market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-viral Gene Delivery System in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Delivery System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Market Segmentation
By Company:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Adaptimmune
Krystal Biotech
Vertex Pharmaceuticals
CSL Behring
By Type: (Dominant Segment vs High-Margin Innovation)
Viral Gene Delivery System
Non-viral Gene Delivery System
By Application: (Core Demand Driver vs Emerging Opportunity)
Neurological Diseases
Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Biogen in Europe)
- Emerging Product Trends: Viral Gene Delivery System adoption vs. Non-viral Gene Delivery System premiumization
- Demand-Side Dynamics: Neurological Diseases growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Gene Delivery System market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-viral Gene Delivery System in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Gene Delivery System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Gene Delivery System Revenue Market Share by Region (2020-2025)
2.4 Global Gene Delivery System Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Gene Delivery System Market Size and Prospective (2020-2031)
2.5.2 Europe Gene Delivery System Market Size and Prospective (2020-2031)
2.5.3 China Gene Delivery System Market Size and Prospective (2020-2031)
2.5.4 Japan Gene Delivery System Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Gene Delivery System Historic Market Size by Type (2020-2025)
3.2 Global Gene Delivery System Forecasted Market Size by Type (2026-2031)
3.3 Different Types Gene Delivery System Representative Players
4 Breakdown Data by Application
4.1 Global Gene Delivery System Historic Market Size by Application (2020-2025)
4.2 Global Gene Delivery System Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Gene Delivery System Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Gene Delivery System Players by Revenue (2020-2025)
5.1.2 Global Gene Delivery System Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Gene Delivery System Revenue
5.4 Global Gene Delivery System Market Concentration Analysis
5.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2024
5.5 Global Key Players of Gene Delivery System Head office and Area Served
5.6 Global Key Players of Gene Delivery System, Product and Application
5.7 Global Key Players of Gene Delivery System, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Gene Delivery System Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Gene Delivery System Market Size by Type (2020-2025)
6.1.2.2 North America Gene Delivery System Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Gene Delivery System Market Size by Application (2020-2025)
6.1.3.2 North America Gene Delivery System Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Gene Delivery System Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Gene Delivery System Market Size by Type (2020-2025)
6.2.2.2 Europe Gene Delivery System Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Gene Delivery System Market Size by Application (2020-2025)
6.2.3.2 Europe Gene Delivery System Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Gene Delivery System Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Gene Delivery System Market Size by Type (2020-2025)
6.3.2.2 China Gene Delivery System Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Gene Delivery System Market Size by Application (2020-2025)
6.3.3.2 China Gene Delivery System Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Gene Delivery System Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Gene Delivery System Market Size by Type (2020-2025)
6.4.2.2 Japan Gene Delivery System Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Gene Delivery System Market Size by Application (2020-2025)
6.4.3.2 Japan Gene Delivery System Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Biogen
7.1.1 Biogen Company Details
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Delivery System Introduction
7.1.4 Biogen Revenue in Gene Delivery System Business (2020-2025)
7.1.5 Biogen Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Delivery System Introduction
7.2.4 Novartis Revenue in Gene Delivery System Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Details
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Delivery System Introduction
7.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2020-2025)
7.3.5 Gilead Sciences Recent Development
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Details
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Delivery System Introduction
7.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.4.5 Sarepta Therapeutics Recent Development
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Details
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
7.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
7.5.5 Alnylam Pharmaceuticals Recent Development
7.6 Amgen
7.6.1 Amgen Company Details
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Delivery System Introduction
7.6.4 Amgen Revenue in Gene Delivery System Business (2020-2025)
7.6.5 Amgen Recent Development
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Details
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Delivery System Introduction
7.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.7.5 Spark Therapeutics Recent Development
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Details
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Delivery System Introduction
7.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.8.5 Akcea Therapeutics Recent Development
7.9 Sunway Biotech
7.9.1 Sunway Biotech Company Details
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene Delivery System Introduction
7.9.4 Sunway Biotech Revenue in Gene Delivery System Business (2020-2025)
7.9.5 Sunway Biotech Recent Development
7.10 SIBIONO
7.10.1 SIBIONO Company Details
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene Delivery System Introduction
7.10.4 SIBIONO Revenue in Gene Delivery System Business (2020-2025)
7.10.5 SIBIONO Recent Development
7.11 AnGes
7.11.1 AnGes Company Details
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene Delivery System Introduction
7.11.4 AnGes Revenue in Gene Delivery System Business (2020-2025)
7.11.5 AnGes Recent Development
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Company Details
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene Delivery System Introduction
7.12.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.12.5 Orchard Therapeutics Recent Development
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Details
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene Delivery System Introduction
7.13.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025)
7.13.5 Human Stem Cells Institute Recent Development
7.14 Adaptimmune
7.14.1 Adaptimmune Company Details
7.14.2 Adaptimmune Business Overview
7.14.3 Adaptimmune Gene Delivery System Introduction
7.14.4 Adaptimmune Revenue in Gene Delivery System Business (2020-2025)
7.14.5 Adaptimmune Recent Development
7.15 Krystal Biotech
7.15.1 Krystal Biotech Company Details
7.15.2 Krystal Biotech Business Overview
7.15.3 Krystal Biotech Gene Delivery System Introduction
7.15.4 Krystal Biotech Revenue in Gene Delivery System Business (2020-2025)
7.15.5 Krystal Biotech Recent Development
7.16 Vertex Pharmaceuticals
7.16.1 Vertex Pharmaceuticals Company Details
7.16.2 Vertex Pharmaceuticals Business Overview
7.16.3 Vertex Pharmaceuticals Gene Delivery System Introduction
7.16.4 Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
7.16.5 Vertex Pharmaceuticals Recent Development
7.17 CSL Behring
7.17.1 CSL Behring Company Details
7.17.2 CSL Behring Business Overview
7.17.3 CSL Behring Gene Delivery System Introduction
7.17.4 CSL Behring Revenue in Gene Delivery System Business (2020-2025)
7.17.5 CSL Behring Recent Development
8 Gene Delivery System Market Dynamics
8.1 Gene Delivery System Industry Trends
8.2 Gene Delivery System Market Drivers
8.3 Gene Delivery System Market Challenges
8.4 Gene Delivery System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Delivery System Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Gene Delivery System Revenue Market Share by Region (2020-2025)
2.4 Global Gene Delivery System Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Gene Delivery System Market Size and Prospective (2020-2031)
2.5.2 Europe Gene Delivery System Market Size and Prospective (2020-2031)
2.5.3 China Gene Delivery System Market Size and Prospective (2020-2031)
2.5.4 Japan Gene Delivery System Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Gene Delivery System Historic Market Size by Type (2020-2025)
3.2 Global Gene Delivery System Forecasted Market Size by Type (2026-2031)
3.3 Different Types Gene Delivery System Representative Players
4 Breakdown Data by Application
4.1 Global Gene Delivery System Historic Market Size by Application (2020-2025)
4.2 Global Gene Delivery System Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Gene Delivery System Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Gene Delivery System Players by Revenue (2020-2025)
5.1.2 Global Gene Delivery System Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Gene Delivery System Revenue
5.4 Global Gene Delivery System Market Concentration Analysis
5.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2024
5.5 Global Key Players of Gene Delivery System Head office and Area Served
5.6 Global Key Players of Gene Delivery System, Product and Application
5.7 Global Key Players of Gene Delivery System, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Gene Delivery System Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Gene Delivery System Market Size by Type (2020-2025)
6.1.2.2 North America Gene Delivery System Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Gene Delivery System Market Size by Application (2020-2025)
6.1.3.2 North America Gene Delivery System Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Gene Delivery System Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Gene Delivery System Market Size by Type (2020-2025)
6.2.2.2 Europe Gene Delivery System Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Gene Delivery System Market Size by Application (2020-2025)
6.2.3.2 Europe Gene Delivery System Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Gene Delivery System Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Gene Delivery System Market Size by Type (2020-2025)
6.3.2.2 China Gene Delivery System Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Gene Delivery System Market Size by Application (2020-2025)
6.3.3.2 China Gene Delivery System Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Gene Delivery System Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Gene Delivery System Market Size by Type (2020-2025)
6.4.2.2 Japan Gene Delivery System Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Gene Delivery System Market Size by Application (2020-2025)
6.4.3.2 Japan Gene Delivery System Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Biogen
7.1.1 Biogen Company Details
7.1.2 Biogen Business Overview
7.1.3 Biogen Gene Delivery System Introduction
7.1.4 Biogen Revenue in Gene Delivery System Business (2020-2025)
7.1.5 Biogen Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Gene Delivery System Introduction
7.2.4 Novartis Revenue in Gene Delivery System Business (2020-2025)
7.2.5 Novartis Recent Development
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Details
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Gene Delivery System Introduction
7.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2020-2025)
7.3.5 Gilead Sciences Recent Development
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Company Details
7.4.2 Sarepta Therapeutics Business Overview
7.4.3 Sarepta Therapeutics Gene Delivery System Introduction
7.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.4.5 Sarepta Therapeutics Recent Development
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Company Details
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction
7.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
7.5.5 Alnylam Pharmaceuticals Recent Development
7.6 Amgen
7.6.1 Amgen Company Details
7.6.2 Amgen Business Overview
7.6.3 Amgen Gene Delivery System Introduction
7.6.4 Amgen Revenue in Gene Delivery System Business (2020-2025)
7.6.5 Amgen Recent Development
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Details
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Gene Delivery System Introduction
7.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.7.5 Spark Therapeutics Recent Development
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Company Details
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Gene Delivery System Introduction
7.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.8.5 Akcea Therapeutics Recent Development
7.9 Sunway Biotech
7.9.1 Sunway Biotech Company Details
7.9.2 Sunway Biotech Business Overview
7.9.3 Sunway Biotech Gene Delivery System Introduction
7.9.4 Sunway Biotech Revenue in Gene Delivery System Business (2020-2025)
7.9.5 Sunway Biotech Recent Development
7.10 SIBIONO
7.10.1 SIBIONO Company Details
7.10.2 SIBIONO Business Overview
7.10.3 SIBIONO Gene Delivery System Introduction
7.10.4 SIBIONO Revenue in Gene Delivery System Business (2020-2025)
7.10.5 SIBIONO Recent Development
7.11 AnGes
7.11.1 AnGes Company Details
7.11.2 AnGes Business Overview
7.11.3 AnGes Gene Delivery System Introduction
7.11.4 AnGes Revenue in Gene Delivery System Business (2020-2025)
7.11.5 AnGes Recent Development
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Company Details
7.12.2 Orchard Therapeutics Business Overview
7.12.3 Orchard Therapeutics Gene Delivery System Introduction
7.12.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025)
7.12.5 Orchard Therapeutics Recent Development
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Details
7.13.2 Human Stem Cells Institute Business Overview
7.13.3 Human Stem Cells Institute Gene Delivery System Introduction
7.13.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025)
7.13.5 Human Stem Cells Institute Recent Development
7.14 Adaptimmune
7.14.1 Adaptimmune Company Details
7.14.2 Adaptimmune Business Overview
7.14.3 Adaptimmune Gene Delivery System Introduction
7.14.4 Adaptimmune Revenue in Gene Delivery System Business (2020-2025)
7.14.5 Adaptimmune Recent Development
7.15 Krystal Biotech
7.15.1 Krystal Biotech Company Details
7.15.2 Krystal Biotech Business Overview
7.15.3 Krystal Biotech Gene Delivery System Introduction
7.15.4 Krystal Biotech Revenue in Gene Delivery System Business (2020-2025)
7.15.5 Krystal Biotech Recent Development
7.16 Vertex Pharmaceuticals
7.16.1 Vertex Pharmaceuticals Company Details
7.16.2 Vertex Pharmaceuticals Business Overview
7.16.3 Vertex Pharmaceuticals Gene Delivery System Introduction
7.16.4 Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025)
7.16.5 Vertex Pharmaceuticals Recent Development
7.17 CSL Behring
7.17.1 CSL Behring Company Details
7.17.2 CSL Behring Business Overview
7.17.3 CSL Behring Gene Delivery System Introduction
7.17.4 CSL Behring Revenue in Gene Delivery System Business (2020-2025)
7.17.5 CSL Behring Recent Development
8 Gene Delivery System Market Dynamics
8.1 Gene Delivery System Industry Trends
8.2 Gene Delivery System Market Drivers
8.3 Gene Delivery System Market Challenges
8.4 Gene Delivery System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Gene Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Gene Delivery System Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Gene Delivery System Revenue Share by Region (2020-2025)
Table 6. Global Gene Delivery System Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Gene Delivery System Revenue Share Forecast by Region (2026-2031)
Table 8. Global Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Gene Delivery System Revenue Market Share by Type (2020-2025)
Table 10. Global Gene Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Gene Delivery System Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Gene Delivery System Revenue Market Share by Application (2020-2025)
Table 15. Global Gene Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Gene Delivery System Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Gene Delivery System Application
Table 18. Global Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Gene Delivery System Market Share by Players (2020-2025)
Table 20. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
Table 21. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Gene Delivery System, Headquarters and Area Served
Table 24. Global Key Players of Gene Delivery System, Product and Application
Table 25. Global Key Players of Gene Delivery System, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 29. North America Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 33. Europe Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 37. China Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 41. Japan Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 43. Biogen Company Details
Table 44. Biogen Business Overview
Table 45. Biogen Gene Delivery System Product
Table 46. Biogen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 47. Biogen Recent Development
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Gene Delivery System Product
Table 51. Novartis Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Gilead Sciences Company Details
Table 54. Gilead Sciences Business Overview
Table 55. Gilead Sciences Gene Delivery System Product
Table 56. Gilead Sciences Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 57. Gilead Sciences Recent Development
Table 58. Sarepta Therapeutics Company Details
Table 59. Sarepta Therapeutics Business Overview
Table 60. Sarepta Therapeutics Gene Delivery System Product
Table 61. Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 62. Sarepta Therapeutics Recent Development
Table 63. Alnylam Pharmaceuticals Company Details
Table 64. Alnylam Pharmaceuticals Business Overview
Table 65. Alnylam Pharmaceuticals Gene Delivery System Product
Table 66. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 67. Alnylam Pharmaceuticals Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Gene Delivery System Product
Table 71. Amgen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Spark Therapeutics Company Details
Table 74. Spark Therapeutics Business Overview
Table 75. Spark Therapeutics Gene Delivery System Product
Table 76. Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 77. Spark Therapeutics Recent Development
Table 78. Akcea Therapeutics Company Details
Table 79. Akcea Therapeutics Business Overview
Table 80. Akcea Therapeutics Gene Delivery System Product
Table 81. Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 82. Akcea Therapeutics Recent Development
Table 83. Sunway Biotech Company Details
Table 84. Sunway Biotech Business Overview
Table 85. Sunway Biotech Gene Delivery System Product
Table 86. Sunway Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 87. Sunway Biotech Recent Development
Table 88. SIBIONO Company Details
Table 89. SIBIONO Business Overview
Table 90. SIBIONO Gene Delivery System Product
Table 91. SIBIONO Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 92. SIBIONO Recent Development
Table 93. AnGes Company Details
Table 94. AnGes Business Overview
Table 95. AnGes Gene Delivery System Product
Table 96. AnGes Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 97. AnGes Recent Development
Table 98. Orchard Therapeutics Company Details
Table 99. Orchard Therapeutics Business Overview
Table 100. Orchard Therapeutics Gene Delivery System Product
Table 101. Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 102. Orchard Therapeutics Recent Development
Table 103. Human Stem Cells Institute Company Details
Table 104. Human Stem Cells Institute Business Overview
Table 105. Human Stem Cells Institute Gene Delivery System Product
Table 106. Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 107. Human Stem Cells Institute Recent Development
Table 108. Adaptimmune Company Details
Table 109. Adaptimmune Business Overview
Table 110. Adaptimmune Gene Delivery System Product
Table 111. Adaptimmune Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 112. Adaptimmune Recent Development
Table 113. Krystal Biotech Company Details
Table 114. Krystal Biotech Business Overview
Table 115. Krystal Biotech Gene Delivery System Product
Table 116. Krystal Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 117. Krystal Biotech Recent Development
Table 118. Vertex Pharmaceuticals Company Details
Table 119. Vertex Pharmaceuticals Business Overview
Table 120. Vertex Pharmaceuticals Gene Delivery System Product
Table 121. Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 122. Vertex Pharmaceuticals Recent Development
Table 123. CSL Behring Company Details
Table 124. CSL Behring Business Overview
Table 125. CSL Behring Gene Delivery System Product
Table 126. CSL Behring Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 127. CSL Behring Recent Development
Table 128. Gene Delivery System Market Trends
Table 129. Gene Delivery System Market Drivers
Table 130. Gene Delivery System Market Challenges
Table 131. Gene Delivery System Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Delivery System Product Picture
Figure 2. Global Gene Delivery System Market Share by Type: 2024 VS 2031
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Delivery System Market Share by Application: 2024 VS 2031
Figure 6. Neurological Diseases
Figure 7. Cancer
Figure 8. Others
Figure 9. Gene Delivery System Report Years Considered
Figure 10. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gene Delivery System Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Gene Delivery System Market Share by Players in 2024
Figure 18. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2024
Figure 20. North America Gene Delivery System Market Share by Type (2020-2025)
Figure 21. North America Gene Delivery System Market Share by Application (2020-2025)
Figure 22. Europe Gene Delivery System Market Share by Type (2020-2025)
Figure 23. Europe Gene Delivery System Market Share by Application (2020-2025)
Figure 24. China Gene Delivery System Market Share by Type (2020-2025)
Figure 25. China Gene Delivery System Market Share by Application (2020-2025)
Figure 26. Japan Gene Delivery System Market Share by Type (2020-2025)
Figure 27. Japan Gene Delivery System Market Share by Application (2020-2025)
Figure 28. Biogen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 29. Novartis Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 30. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 31. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 32. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 33. Amgen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 34. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 35. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 36. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 37. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 38. AnGes Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 39. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 40. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 41. Adaptimmune Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 42. Krystal Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 43. Vertex Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 44. CSL Behring Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Gene Delivery System Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Gene Delivery System Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Gene Delivery System Revenue Share by Region (2020-2025)
Table 6. Global Gene Delivery System Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Gene Delivery System Revenue Share Forecast by Region (2026-2031)
Table 8. Global Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Gene Delivery System Revenue Market Share by Type (2020-2025)
Table 10. Global Gene Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Gene Delivery System Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Gene Delivery System Revenue Market Share by Application (2020-2025)
Table 15. Global Gene Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Gene Delivery System Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Gene Delivery System Application
Table 18. Global Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Gene Delivery System Market Share by Players (2020-2025)
Table 20. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
Table 21. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Gene Delivery System, Headquarters and Area Served
Table 24. Global Key Players of Gene Delivery System, Product and Application
Table 25. Global Key Players of Gene Delivery System, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 29. North America Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 33. Europe Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 37. China Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Gene Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Gene Delivery System Revenue Market Share by Company (2020-2025)
Table 41. Japan Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 43. Biogen Company Details
Table 44. Biogen Business Overview
Table 45. Biogen Gene Delivery System Product
Table 46. Biogen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 47. Biogen Recent Development
Table 48. Novartis Company Details
Table 49. Novartis Business Overview
Table 50. Novartis Gene Delivery System Product
Table 51. Novartis Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Gilead Sciences Company Details
Table 54. Gilead Sciences Business Overview
Table 55. Gilead Sciences Gene Delivery System Product
Table 56. Gilead Sciences Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 57. Gilead Sciences Recent Development
Table 58. Sarepta Therapeutics Company Details
Table 59. Sarepta Therapeutics Business Overview
Table 60. Sarepta Therapeutics Gene Delivery System Product
Table 61. Sarepta Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 62. Sarepta Therapeutics Recent Development
Table 63. Alnylam Pharmaceuticals Company Details
Table 64. Alnylam Pharmaceuticals Business Overview
Table 65. Alnylam Pharmaceuticals Gene Delivery System Product
Table 66. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 67. Alnylam Pharmaceuticals Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Gene Delivery System Product
Table 71. Amgen Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. Spark Therapeutics Company Details
Table 74. Spark Therapeutics Business Overview
Table 75. Spark Therapeutics Gene Delivery System Product
Table 76. Spark Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 77. Spark Therapeutics Recent Development
Table 78. Akcea Therapeutics Company Details
Table 79. Akcea Therapeutics Business Overview
Table 80. Akcea Therapeutics Gene Delivery System Product
Table 81. Akcea Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 82. Akcea Therapeutics Recent Development
Table 83. Sunway Biotech Company Details
Table 84. Sunway Biotech Business Overview
Table 85. Sunway Biotech Gene Delivery System Product
Table 86. Sunway Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 87. Sunway Biotech Recent Development
Table 88. SIBIONO Company Details
Table 89. SIBIONO Business Overview
Table 90. SIBIONO Gene Delivery System Product
Table 91. SIBIONO Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 92. SIBIONO Recent Development
Table 93. AnGes Company Details
Table 94. AnGes Business Overview
Table 95. AnGes Gene Delivery System Product
Table 96. AnGes Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 97. AnGes Recent Development
Table 98. Orchard Therapeutics Company Details
Table 99. Orchard Therapeutics Business Overview
Table 100. Orchard Therapeutics Gene Delivery System Product
Table 101. Orchard Therapeutics Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 102. Orchard Therapeutics Recent Development
Table 103. Human Stem Cells Institute Company Details
Table 104. Human Stem Cells Institute Business Overview
Table 105. Human Stem Cells Institute Gene Delivery System Product
Table 106. Human Stem Cells Institute Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 107. Human Stem Cells Institute Recent Development
Table 108. Adaptimmune Company Details
Table 109. Adaptimmune Business Overview
Table 110. Adaptimmune Gene Delivery System Product
Table 111. Adaptimmune Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 112. Adaptimmune Recent Development
Table 113. Krystal Biotech Company Details
Table 114. Krystal Biotech Business Overview
Table 115. Krystal Biotech Gene Delivery System Product
Table 116. Krystal Biotech Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 117. Krystal Biotech Recent Development
Table 118. Vertex Pharmaceuticals Company Details
Table 119. Vertex Pharmaceuticals Business Overview
Table 120. Vertex Pharmaceuticals Gene Delivery System Product
Table 121. Vertex Pharmaceuticals Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 122. Vertex Pharmaceuticals Recent Development
Table 123. CSL Behring Company Details
Table 124. CSL Behring Business Overview
Table 125. CSL Behring Gene Delivery System Product
Table 126. CSL Behring Revenue in Gene Delivery System Business (2020-2025) & (US$ Million)
Table 127. CSL Behring Recent Development
Table 128. Gene Delivery System Market Trends
Table 129. Gene Delivery System Market Drivers
Table 130. Gene Delivery System Market Challenges
Table 131. Gene Delivery System Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Delivery System Product Picture
Figure 2. Global Gene Delivery System Market Share by Type: 2024 VS 2031
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Delivery System Market Share by Application: 2024 VS 2031
Figure 6. Neurological Diseases
Figure 7. Cancer
Figure 8. Others
Figure 9. Gene Delivery System Report Years Considered
Figure 10. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gene Delivery System Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Gene Delivery System Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Global Gene Delivery System Market Share by Players in 2024
Figure 18. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2024
Figure 20. North America Gene Delivery System Market Share by Type (2020-2025)
Figure 21. North America Gene Delivery System Market Share by Application (2020-2025)
Figure 22. Europe Gene Delivery System Market Share by Type (2020-2025)
Figure 23. Europe Gene Delivery System Market Share by Application (2020-2025)
Figure 24. China Gene Delivery System Market Share by Type (2020-2025)
Figure 25. China Gene Delivery System Market Share by Application (2020-2025)
Figure 26. Japan Gene Delivery System Market Share by Type (2020-2025)
Figure 27. Japan Gene Delivery System Market Share by Application (2020-2025)
Figure 28. Biogen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 29. Novartis Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 30. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 31. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 32. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 33. Amgen Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 34. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 35. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 36. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 37. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 38. AnGes Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 39. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 40. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 41. Adaptimmune Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 42. Krystal Biotech Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 43. Vertex Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 44. CSL Behring Revenue Growth Rate in Gene Delivery System Business (2020-2025)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232